Dr. K. Dodge, PhD, MSPH, MSW

Dr. Dodge is the Director of Neuro Rehabilitation Services at Behavioral Health Centers. She is also Research Faculty at the Charles E. Schmidt School of Science; Department of Complex Systems and Brain Sciences.

Dr. Dodge’s work has been published in numerous peer-reviewed Journals, most recently, Nature: Genetics. (2018), Journal of Addictive Disorders and their treatment (2017), Journal of Drug Issues (2012), Journal of Substance Abuse Treatment Prevention and Policy (2016), the Journal of Substance Abuse Treatment (2011), and John’s Hopkins Journal of Health for the Poor and Underserved (2009).

Dr. Dodge has conducted and published pioneering studies in the specific areas of The Effectiveness of Female-Sensitive Substance Abuse Treatment as compared to Traditional Mixed Gender Models. The impact of Therapist Client Congruence on Chemical Dependency Treatment Outcomes and Why HIV Women of Color Who are Substance Abusers and Aware of their HIV Status elect not to seek Primary Health Care or Substance Abuse Treatment. This work has yielded groundbreaking changes in the treatment delivery for chemically dependent females as evidenced by a local provider; The Orchids treatment procedures.

Commencing in 2012, Dr. Dodge was the Co-Principal investigator of a five-year study collaborating with the University of Miami, Scripts Research Institute and the University of New Mexico’s Mind Research Network to examine the interface between non-coding RNA’s and brain images (SPECT scans) to diagnosis addiction and develop novel therapeutics to address such diagnosis. Finally, these blood biomarkers and SPECT images are being explored as Prognosticative tools to predict relapse.